Efficacy and Safety of Anlotinib in the Treatment of Small Cell Lung Cancer: A Real-World Observation Study

Efficacy and Safety of Anlotinib in the Treatment of Small Cell Lung Cancer: A Real-World Observation Study

AimsThis study aimed to observe the efficacy and safety of anlotinib in the treatment of small cell lung cancer (SCLC) in the real world, as first-line maintenance therapy, second-line, and above.MethodsClinical data of 109 patients with SCLC treated with anlotinib and hospitalized at The First Affi...

Full description

Bibliographic Details
Main Authors: Jing Yuan, Feng Cheng, Guodong Xiao, Xiaofeng Wang, Huijie Fan
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-06-01
Series:Frontiers in Oncology
Subjects:
small cell lung cancer
anlotinib
maintenance therapy
second-line treatment
third-line treatment
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.917089/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.917089/full

Similar Items